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Pharmaceutical analysisAbstract One titrimetric and two spectrophotometric procedures have been developed for the
assay of carbamazepine (CBZ) in bulk drug, formulations and spiked human urine. The methods
are based on the bromination of CBZ by the bromine generated in situ by the action of the acid
on the bromate–bromide mixture. The twin advantages of avoiding liquid bromine and analysis
in a cost-effective manner are realized. In titrimetry, the drug was treated with a known excess
of bromate–bromide mixture in hydrochloric acid medium followed by the determination of unre-
acted bromine iodometrically. Spectrophotometry involves the addition of a measured excess of
bromate–bromide reagent in acid medium to CBZ, and after the reaction is ensured to be complete,
the residual bromine was determined by reacting with a ﬁxed amount of either methyl orange and
measuring the absorbance at 510 nm (method A) or indigo carmine and measuring the absorbance
at 610 nm (method B). Titrimetric procedure is applicable over the range of 1.00–7.50 mg CBZ, and
the calculations are based on a 1:1 reaction stoichiometry (CBZ:KBrO3). In spectrophotometric
methods, Beer’s law is valid within concentration ranges of 0.25–1.50 and 0.50–6.00 lg ml1
CBZ for methods A and B, respectively. The proposed methods were successfully applied to the
determination of CBZ in tablets and syrup, in addition to spiked human urine by the spectropho-
tometric methods, with mean recoveries of 95.50–104.0% and the results were statistically com-
pared with those of an ofﬁcial method by applying Student’s t-test and F-test.
ª 2010 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Carbamazepine (CBZ), chemically known as 5H-dibenz-[b,f]-aze-
pine-5-carboxamide (Merck Index, 2006), is an anticonvulsant
and mood stabilizing drug used primarily in the treatment of epi-
lepsy and bipolar disorder, as well as trigeminal neuralgia. The
drug is ofﬁcial in the British Pharmacopoeia (1973) which de-
scribes a UV-spectrophotometric method for its assay in tablets.
Since its introduction into clinicalmedicine in themid-1960s, liter-
ature on the methods for the determination of CBZ in biological
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number of techniques have been reported for the assay of CBZ
in pharmaceutical dosage forms and includeHPLC (Panchagnula
et al., 1998; Tatar Ulu, 2006; Demirkaya and Kadioglu, 2005,
2008; Yuan et al., 2003), LC (Predrag et al., 2009; Walker,
1988), GC (Kadioglu andDemirkaya, 2007; Liu et al., 1991), ﬂow
injection-spectrophotometry (C¸omog˘lu et al., 2006), FI-spectro-
ﬂuorimetry (Huang et al., 2002), chemiluminescence (CL) (Lee
et al., 2003), FI-CL (Xiong et al., 2009), electrolysis-ﬂuorescence
(Pan and Yao, 1998), polarography (Pachecka and Giovanoli,
1982), UV-spectrophotometry (Tatar Ulu, 2006; Demirkaya and
Kadioglu, 2008) and visible spectrophotometry (Rao andMurty,
1982; Agrawal et al., 1989). All these methods are reviewed in Ta-
bles 1 and 2.
In spite of the suitability of the proposed methods, many re-
quire expensive instruments or materials such as chromato-
graphic, ﬂow injection and chemiluminescence techniques.
Besides, chromatographic methods (Panchagnula et al., 1998;
Tatar Ulu, 2006; Yuan et al., 2003; Predrag et al., 2009; Walk-
er, 1988; Kadioglu and Demirkaya, 2007; Liu et al., 1991) need
a suitable compound as internal standard, which makes the
procedure more complex. Visible spectrophotometry, because
of its simplicity and cost effectiveness, sensitivity and selectiv-
ity, fair accuracy, precision and easy access in most quality
control laboratories, has remained competitive in an area of
chromatographic techniques for pharmaceutical analysis.
To the best of our knowledge, no titrimetric method has ever
been reported and there are only two reports on the use of vis-
ible spectrophotometry for the determination of CBZ in phar-
maceuticals. The ﬁrst report (Rao andMurty, 1982) is based on
the oxidation of CBZ with sodium metaperiodate in acidic
medium after heating for 1 h, extraction of the chromogen into
n-butanol before measuring the absorbance at 410 nm. The sec-
ond method (Agrawal et al., 1989) is based on the reaction of
amide group in CBZ with hydroxylammonium chloride–NaOH
under hot conditions, followed by reaction with ferric chloride
in HCl medium and measuring the absorbance at 510 nm. The
visible spectrophotometric methods currently available (Rao
and Murty, 1982; Agrawal et al., 1989) involve extraction or
heating step and their sensitivity is poor.Table 1 Chromatographic methods reported for the determination
Technique Chromatographic conditions
Mobile phase Flow rate
(ml min1)
HPLC 0.01 M potassium phosphate buﬀer of pH
7/acetonitrile/methanol (11:5:3)
1.0
HPLC Acetonitrile:water (75:25, v/v) 1.0
HPLC Acetonitrile–Milli-Q grade water (30:70,
v/v)
1.0
HPLC (28:72, v/v) acetonitrile:0.02 M sodium
phosphate buﬀer (pH 7.8)
1.0
HPLC–DAD Acetonitrile–Milli-Q grade water (30:70,
v/v)
1.0
LC (50:50, v/v) methanol–10 mM ammonium
acetate buﬀer, pH adjusted to 2.21 with
glacial acetic acid
1.5
LC THF–methanol–water (8:37:55) 1.0
GC
GC Carrier gas is nitrogen 20The scientiﬁc references found in the CAS and SCI database,
relating to green analytical chemistry or environmental-friendly
analytical methods have been growing signiﬁcantly in recent
years (Armenta et al., 2008). The recent development of new
analytical methods with good characteristics such as selectivity
and sensitivity is not sufﬁcient; modern analytical methods need
to be green (Sharma et al., 2003; Vidotti et al., 2004). Hence, the
purpose of this study was to develop three new methods for the
determination of CBZ based on bromination of CBZ by a green
brominating agent (i.e. bromine-generated in situ). Themethods
employ titrimetric and spectrophotometric techniques, and use
bromate–bromide mixture, methyl orange (MO) and indigo
carmine (IC) as reagents. The proposed methods have the
advantage of accuracy and precision besides being free from
interference from common tablet excipients.
2. Experimental
2.1. Apparatus
All the absorbance spectral measurements were made using a
Systronics model 106 digital spectrophotometer equipped with
1 cm matched quartz cells.
2.2. Materials and reagents
Pharmaceutical grade carbamazepine (CBZ) was received from
Jubilant Organosys Ltd., Mysore, India, as a gift and used as
received. All pharmaceutical preparations were obtained from
commercial sources in the local market. All reagents and
chemicals used were of analytical reagent grade and distilled
water was used throughout the study.
A standard stock solution of bromate–bromide mixture
equivalent to 5 mM KBrO3 and 10-fold molar excess of KBr
was prepared by dissolving accurately weighed 0.209 g of
potassium bromate (s.d. ﬁne-chem Ltd., Mumbai, India) and
1.488 g of potassium bromide (Merck, Mumbai, India) in
water and diluting to volume in a 250 ml calibrated ﬂask,
and used in titrimetric method. Another stock standard
solution of KBrO3–KBr equivalent to 200 lg ml
1 KBrO3of CBZ in pharmaceuticals.
LOD
(lg ml1)
Rang
(lg ml1)
References
Detection
At 214 nm 0.100 Panchagnula et al. (1998)
At 285 nm 0.055 0.2–2.0 Tatar Ulu (2006)
UV at 220 nm 0.05 0.25–25 Demirkaya and Kadioglu
(2005)
UV at 230 nm 0.018 5.0–25.0 Yuan et al. (2003)
At 220 nm 0.05 0.25–25 Demirkaya and Kadioglu
(2008)
UV at 260 nm 0.0125 100–500 Predrag et al. (2009)
At 254 nm 0.2–1.7 Walker (1988)
FID 2–30 Kadioglu and Demirkaya
(2007)
FID Liu et al. (1991)
Table 2 Non-chromatographic techniques reported for the determination of CBZ in pharmaceuticals.
Technique Method kmax LOD Range References
UV-spectrophotometry The ‘‘peak-to-peak amplitudes’’ was measured at
the respected wavelength
270.6/282.6 1.25 lg ml1 4.0–10 lg ml1 Tatar Ulu (2006)
First order-derivative UV-
spectrophotometry
The ‘‘peak-to-peak amplitudes’’ was measured at
the respected wavelengths
285 nm 0.25 lg ml1 1.25–25 lg ml1 Demirkaya and Kadioglu
(2008)
Second order-derivative UV-
spectrophotometry
287 nm 0.25 lg ml1 1.25–25 lg ml1
FI spectrophotometry The carrier solvent was 1% SDS, and certain FIA
parameters were examined to ﬁnd the optimum
conditions, such as wavelength of detection, ﬂow
rate, and injection volume
288 nm 8.34 · 107 M 1.08 · 105–6.48 · 105 M C¸omog˘lu et al. (2006)
FI photochemical
spectroﬂuorimetry
CBZ was converted to a strongly ﬂuorescent
compound upon on-line photochemical reaction
in a dilute HCl
kem = 478 nm 0.08 ng ml
1 2–250 ng ml1 Huang et al. (2002)
kex = 254 nm
Chemiluminescence (CL) Based on the chemiluminescence produced in the
reaction of tris(2,20-bipyridine) ruthenium(III)
and CBZ in an acidic medium
kmax = 675 nm 2.5 · 107 mol l1 4.0 · 103–8.6 · 107 mol l1 Lee et al. (2003)
FI-CL Based on that CBZ could signiﬁcantly enhance the
weak chemiluminescence (CL) of the reaction of
potassium permanganate and sodium sulﬁte
2.0 · 1010 g ml1 1.0 · 109–1.0 · 106 g ml1 Xiong et al. (2009)
Electrolysis-ﬂuorescence CBZ was treated with Mn(II), H2SO4 and anhy.
ethanol. After electrolysis with a Pt-wire electrode
by applying a voltage of 1.2 V, the ﬂuorescence
intensity due to oxidation of CBZ was measured
Fluorescence intensity
measured at 478 nm, and
excitation at 254 nm
0.8 nM 8.4 nM–1.76 lM Pan and Yao (1998)
Polarography Pachecka and Giovanoli
(1982)
Visible spectrophotometry Based on the oxidation of CBZ with sodium
metaperiodate in acidic medium, then extraction
the chromogen into n-butanol
410 nm NA 10–100 lg ml1 Rao and Murty (1982)
Visible spectrophotometry Based on the reaction of amide group in CBZ with
hydroxylammonium chloride, followed by
reaction with ferric chloride in HCl medium
510 nm 4–80 lg ml1 Agrawal et al. (1989)
Visible spectrophotometry Based on the reaction of CBZ with a measured
excess of bromate–bromide mixture in acid
medium and determining the residual bromine by
Present methods
(a) reacting with a ﬁxed amount of methyl orange
and measuring the absorbance at 510 nm
510 nm 0.05 lg ml1 0.25–1.50 lg ml1
(b) reacting with a ﬁxed amount of indigo carmine
and measuring the absorbance at 610 nm
610 nm 0.14 lg ml1 0.50–6.00 lg ml1
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Figure 1 Absorption spectra of: (1) methyl orange in acid
(2.5 lg ml1 of MO); (2) blank for methyl orange; (3) indigo
carmine in acid (10 lg ml1 of IC); (4) blank for indigo carmine.
300 K. Basavaiah, S.A.M. Abdulrahmanwas prepared in a 100 ml calibrated ﬂask and diluted with
water to get bromate–bromide solutions containing 12.5 and
50 lg ml1 in KBrO3 for use in spectrophotometric method
A and method B, respectively.
Solutions of 5 M hydrochloric acid (Merck, Mumbai, In-
dia; sp. gr. 1.18), 5% potassium iodide (Merck, Mumbai, In-
dia), 0.03 M sodium thiosulphate (Sisco-chem Industries,
Mumbai, India, assay 98%), 1% starch indicator GR (LOBA
Chemie Pvt. Ltd., Mumbai, India), 60 lg ml1 methyl orange
(s.d. ﬁne-chem Ltd., Mumbai, India) for method A and
200 lg ml1 indigo carmine for method B (LOBA Chemie
Pvt. Ltd., Mumbai, India) were prepared in water.
A stock standard solution equivalent to 1.0 mg ml1 of CBZ
was prepared by dissolving accurately weighed 100 mg of pure
drug in 40 ml methanol and diluted to the mark in a 100 ml cal-
ibrated ﬂask with water. This solution was used in titrimetric
work and diluted appropriately with water to get the working
concentrations of 5.0 and 20 lg ml1 CBZ for use in spectro-
photometric method A and method B, respectively.
2.3. Assay procedures
2.3.1. Titrimetry
A 1.0–7.5 ml aliquot of standard CBZ solution containing
1.00–7.50 mg of CBZ was measured accurately, transferred
into a 100 ml Erlenmeyer ﬂask and the total volume was made
to 10 ml with water. The solution was acidiﬁed by adding 5 ml
of 5 M HCl followed by the addition of 10 ml of bromate–
bromide mixture 5 mM in KBrO3 by means of a pipette. The
content was mixed well and the ﬂask was kept aside for
10 min with occasional swirling. Then, 5 ml of 5% potassium
iodide was added to the ﬂask and the liberated iodine was ti-
trated with 0.03 M sodium thiosulphate to a starch end point.
A blank titration was performed taking 10 ml of water–meth-
anol (3:2) mixture in place of drug solution and the drug con-
tent in the aliquot was calculated from a knowledge of the
amount of KBrO3 reacted.
2.3.2. Spectrophotometry using methyl orange (method A)
Different aliquots (0.0, 0.5, 1.0, 1.5, . . . , 3.0 ml) of a standard
CBZ (5 lg ml1) solution were accurately transferred into a
series of 10 ml calibrated ﬂasks and the total volume was ad-
justed to 3.0 ml by adding adequate quantity of water. To each
ﬂask, 2 ml of 5 M HCl was added followed by 1.0 ml of bro-
mate–bromide (12.5 lg ml1 in KBrO3). The ﬂasks were stop-
pered, content mixed and allowed to stand for 15 min with
occasional shaking. Then, 1.0 ml of methyl orange solution
(60 lg ml1) was added to each ﬂask, and after 5 min, the mix-
ture was diluted to the volume with water and mixed well. The
absorbance of each solution was measured at 510 nm against a
reagent blank.
2.3.3. Spectrophotometry using indigo carmine (method B)
Varying aliquots (0.0, 0.25, 0.5, 1.0, . . . , 3.0 ml) of a standard
20 lg ml1 CBZ solution were transferred into a series of
10 ml calibrated ﬂasks using a micro burette and the total vol-
ume was brought to 3 ml by adding water. To each ﬂask 2 ml
of 5 M HCl and 1.0 ml of bromate–bromide mixture solution
(50 lg ml1 in KBrO3) were added. The content was mixed well
and the ﬂasks were kept aside for 15 min with intermittent shak-
ing. Finally, 1.0 ml of indigo carmine solution (200 lg ml1)
was added to each ﬂask and the volume was adjusted to themark with water. The absorbance of each solution was mea-
sured at 610 nm against a reagent blank.
2.3.4. Assay procedure for tablets
Ten tablets containing CBZ were accurately weighed and
ground into ﬁne powder. A portion of the powder equivalent
to 100 mg of CBZ was accurately weighed into a 100 ml cali-
brated ﬂask, 40 ml of methanol and 20 ml of water were added.
The content was shaken for 15–20 min; the volume was diluted
to the mark with water, mixed well and ﬁltered using a What-
man No. 42 ﬁlter paper. The ﬁrst 10 ml portion of the ﬁltrate
was discarded and a convenient aliquot of the subsequent por-
tion of the ﬁltrate was assayed by titrimetric procedure. The
same tablet extract was appropriately diluted with water to
get 5.0 and 20 lg ml1 w.r.t. CBZ for the assay by the spectro-
photometric methods A and B, respectively.
2.3.5. Assay procedure for syrup
Five milliliters of syrup (Tegrital 100 mg/5 ml) equivalent to
100 mg of CBZ into a 100 ml calibrated ﬂask, 40 ml of metha-
nol and 20 ml of water were added. The content was shaken
for 15–20 min; the volume was diluted to the mark with water
and mixed well. The resulting solution was clear and it was as-
sayed by titrimetric procedure. The same solution was appro-
priately diluted with water to get 5.0 and 20 lg ml1 w.r.t.
CBZ for the assay by the spectrophotometric methods A and
B, respectively.
2.3.6. Assay procedure for spiked human urine by the
spectrophotometric methods
Five milliliters of CBZ free urine taken in a 125 ml separating
funnel was spiked with 5.0 ml of a standard 200 lg ml1 CBZ
solution, the content was mixed well and then extracted with
3 · 10 ml of dichloromethane. The dichloromethane extract
was collected in a beaker containing anhydrous sodium sul-
phate and the water-free organic layer was transferred into a
50 ml dried calibrated ﬂask and the solvent was evaporated
on a hot water bath. The residue was dissolved in 2 ml of meth-
Utilization of bromination reactions for the determination of carbamazepine using bromate–bromide mixture 301anol and the volume was diluted with water up to the mark.
An aliquot of the resulting solution was analyzed using the
procedures of the methods A and B.
3. Results and discussion
Carbamazepine is found to undergo bromination by bromine
generated in situ by the action of the acid on bromate–bromide
mixture. The present work deals with one titrimetric and two
spectrophotometric procedures for the assay of CBZ using
in situ generated bromine as a green brominating agent. Bro-
mine generated in situ by the action of the acid on bromate–
bromide mixture was achieved upon the principles of green
chemistry (Anastas and Warner, 1998) such as replacement
of the highly toxic and hazardous liquid bromine, no forma-
tion of hazardous byproducts, eco-friendly, easily availableN NO3S N
CH3
CH3
Unreacted Br2 +
methyl orange
pink-red in acid medium
max absorbance at 510 nm
H
Unreacted Br2 +
O3S
N
O
N
H
H
O
indigo carmine
blue color
max absorbance at 610 nm
(Method A)
(Method B)
BrO3- + 5Br - + 6H+ 3Br2 + 3H2O
CBZ + Known excess of Br2 Brominated produc
H+
Unreacted Br2 + Excess of KI Liberated iodine is
to a star
H+
(Titrimetry)
N
C
O
NH2
+ 3Br2
Br
H+
CBZ
Figure 2 Tentative reaction scheand monetarily cheap. The proposed methods are indirect
and based on the determination of residual bromine after the
reaction between the drug and bromine is judged to be com-
plete and rely on different reaction schemes. In titrimetry,
the reaction was followed by back titration of the unreacted
bromine iodometrically, whereas in spectrophotometry, the
reaction was followed by measuring the increase in absorbance
of either methyl orange at 510 nm or indigo carmine at 610 nm
(Fig. 1). The absorbance change is caused by the bleaching ac-
tion of residual bromine generated in situ on the dyes (Fig. 2).
3.1. Chemistry
The reaction between carbamazepine and bromine generated
in situ by the action of the acid on bromate–bromide mixture
uses electrophilic substitution as well as addition reactions.N NO3S N
CH3
CH3
Br
2HBr+
colorless product
SO3
O3S
N
O
N
SO3
H
H
OBr
Br
Br
colorless product
2HBr+
t of CBZ + Unreacted Br2
 titrated with Na2S2O3
ch end point
N
C
O
NH2
Br
BrBr
Brominated product of CBZ
+ 2HBr
me for the proposed methods.
302 K. Basavaiah, S.A.M. AbdulrahmanThe presence of the nitrogen atom attached to the benzene
rings will direct the bromination to ortho and para positions
in both the rings but the bromination occurs at the para posi-
tions only due to the steric effect of the amide which leads to a
decrease in the amount of the ortho-product. The addition of
the bromine will occur to the double bond at the C3 and C4 in
the azepine ring (Fig. 2).
The reaction between methyl orange and unreacted bromine
involves aromatic ring substitution as a major reaction (Laiti-
nen and Boyer, 1972) and produces a large decrease in the mo-
lar absorptivity at respective wavelength. The most logical
place for the addition of the ﬁrst bromine is ortho to the
N,N-dimethylamino group as this group is a strongly activating
ortho and para director. Also, the addition of a second mole of
bromine per mole of methyl orange must result in the bromin-
ation of another available position on one of the two rings
(Fig. 2). The bromination will not occur in another ring because
the protonated azo link and the sulfonate group are both deac-
tivating meta directors for aromatic electrophilic substitution.
The reaction between indigo carmine and unreacted bro-
mine involves the bleaching of the dye’s colour by the bromin-
ation of the dye at ortho positions to –NH group of the two
symmetric aromatic rings (Fig. 2).
3.2. Method development
3.2.1. Selection of the solvent
Since carbamazepine is insoluble in water (Merck Index, 2006),
different solvents such as ethanol, acetone and methanol were
tested to prepare the stock standard solution of CBZ. Ethanol
and acetone were unsuitable due to the oxidation of ethanol
(Farkas et al., 1949) and bromination of acetone (Lopez-Cueto
et al., 2002) by the free bromine as follows:
CH3CH2OHþ Br2!kI CH3CHOþ 2HBr
CH3CH2OHþ Br2 þH2O!kII CH3COOHþ 2HBr
k
CH3CH3C
O
CH3CH2C
OH
+ Br2CH3CH2C
OH
fast
CH3C
H2
C
O
Br
Among the tested solvents, methanol was found to be an
ideal solvent for the preparation of the standard solution of
CBZ, and the minimum ratio to get a stable solution was 2:3
(methanol:water) for 1.0 mg ml1 CBZ.
3.2.2. Optimization of reaction conditions
The reaction conditions as well as the various experimental
variables providing accurate and precise results, and affecting
the colour development of the measured species were carefully
optimized.
3.2.2.1. Titrimetry. The proposed titrimetric procedure is based
on the bromination reaction between CBZ and bromine gener-
ated in situ. A (1.00–7.50) mg of CBZ were treated with known
excess of bromate–bromide mixture in acid medium, and back
titrating the residual bromine iodometrically after ensuring the
completion of the reaction. Hydrochloric acid medium was
found to be an ideal and the reaction stoichiometry was unaf-
fected when 2–8 ml of 5 M HCl was used in a total volume of25 ml. Hence, 5 ml of 5 M HCl was used in the titrimetric
study. The reaction was found to be complete in 10 min and
contact time up to 25 min had no effect on the stoichiometry
or the results but after 30 min contact time, small brown par-
ticles were developed due to the formation of brominated
product of CBZ. Ten milliliters volume of 5 mM
KBrO3–50 mM KBr was found adequate for a quantitative
bromination of CBZ in the range investigated.
3.2.2.2. Spectrophotometry. The proposed spectrophotometric
methods are based on the bromination of CBZ by a measured
excess of bromate–bromide mixture in HCl medium. After a
predetermined time, the unreacted bromine was determined
by treating it with a ﬁxed amount of either methyl orange or
indigo carmine dye, and measuring the absorbance either at
510 or 610 nm. The absorbance was found to be linearly
dependent on the CBZ concentration. CBZ, when added in
increasing concentrations to a ﬁxed concentration of in situ
generated bromine, consumes the latter and there will be a con-
comitant decrease in the concentration of bromine. When a
ﬁxed concentration of either dye is added to decreasing con-
centrations of bromine, a concomitant increase in the dye con-
centration results. Consequently, a proportional increase in the
absorbance at the respective kmax is observed with increasing
the concentration of CBZ.
3.2.2.3. Optimization of the concentration of the dyes and
bromate–bromide mixture. Various parameters associated with
the bromination of CBZ, and subsequent destruction of the
dyes by the residual bromine were optimized. Preliminary
experiments were performed to ﬁx the upper concentrations
of the two dyes that could be determined spectrophotometri-
cally in acid medium, and these were found to be 6 and
20 lg ml1 for methyl orange and indigo carmine, respectively.
A bromate concentration of 1.25 lg ml1 in the presence of a
large excess of bromide was found to bleach the pink-red colour
of 6.0 lg ml1 methyl orange, and the blue colour due to
20 lg ml1 indigo carmine was completely destroyed by
5.0 lg ml1 bromate in the presence of excess bromide. Hence,
different concentrations of CBZ were reacted with 1.0 ml of
12.5 lg ml1 bromate in method A and 1.0 ml of 50.0 lg ml1
bromate in method B in acid medium and in the presence of a
large excess of bromide, followed by determination of the resid-
ual bromine as described under the respective procedures.
3.2.2.4. Effect of acid and reaction time. Hydrochloric acid was
found to be a convenient medium for the two steps involved in
both methods and the absorbance of the dyes was not affected
in 0.50–1.25 M HCl. However, since 1.0 M acid concentration
(2 ml of 5 M HCl in a total volume of 10 ml) was found to be
optimum for the bromination reaction in a reasonable time of
15 min in bothmethods, the same concentrationwasmaintained
for the determination of the unreacted bromine with the dyes;
and even this reaction time is not critical. A 5 min standing time
was found to be necessary for the complete bleaching of the
methyl orange colour by the residual bromine, whereas the com-
plete bleaching of the indigo carmine colour was instantaneous.
3.2.3. Colour stability
The absorbance of the measured colour was constant for more
than 24 and 12 h for methods A and B, respectively, even in the
presence of the reaction products.
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3.3.1. Quantitative data
The titrimetric procedure is applicable over the range of 1.00–
7.50 mg of CBZ and the reaction stoichiometry was calculated
to be (1:1) for the reaction between CBZ and KBrO3.
In spectrophotometric procedures, the Beer’s law was
obeyed over the concentration ranges of 0.25–1.50 and 0.50–
6.00 lg ml1 of CBZ for methods A and B, respectively. The
linear plots gave the following regression equations:
A ¼ 0:0123þ 0:4953C for method A
A ¼ 0:0031þ 0:1263C for method B
where A is the absorbance and C is the concentration in
lg ml1. The correlation coefﬁcient (r) of the calibration plotsTable 3 Intra-day and inter-day precision and accuracy studies.
Methoda CBZ taken Intra-day (n= 7)
CBZ foundb Pre
Titrimetry 2.0 2.05 1.4
4.0 4.04 1.0
6.0 5.95 1.2
Spectrophotometric (method A) 0.5 0.51 2.4
1.0 1.03 1.8
1.5 1.47 1.1
Spectrophotometric (method B) 2.0 1.98 2.3
3.0 2.99 2.2
4.0 4.06 1.3
a CBZ taken/found in titrimetric method is in mg and the same in spec
b Mean value of ﬁve determinations.
c Relative standard deviation (%).
d Bias (%) = [(found  taken)/taken] · 100.
Table 4 Results of assay of CBZ formulations using the proposed
Brand name Nominal amount Found (% of nominal amount ± S
Oﬃcial
method
Proposed methods
Titrimetric method
Zeptol tabletsb 100 mg 98.36 ± 1.28 97.50 ± 2.45
t= 0.73
F= 3.66
Tegrital syrupc 100 mg/5 ml 96.72 ± 1.34 95.01 ± 2.06
t= 1.59
F= 2.36
Tabulated t-value at the 95% conﬁdence level is 2.78; tabulated F-value
a Mean value of ﬁve determinations.
b Marketed by Sun Pharmasikkim, ranipool, India.
c Marketed by Piramal Healthcare Limited, Mahad, India.
Table 5 Determination of CBZ in spiked human urine
Method Spiked concentration (
Spectrophotometric (method A) 1.00
Spectrophotometric (method B) 4.00
a Mean value of ﬁve determinations.of the methods A and B is calculated to be 0.9980 and 0.9997,
respectively, conﬁrming a linear increase in the absorbance with
increasing the concentration of the drug. The calculated molar
absorptivities are 1.21 · 105 and 2.91 · 104 l mol1 cm1 for
method A and method B, respectively with corresponding San-
dell sensitivity values of 0.0020 and 0.0081 lg cm2. The limits
of detection (LOD) and limits of quantiﬁcation (LOQ) for the
proposed methods were calculated using the following equa-
tions (ICH, 2005):
LOD ¼ 3:3 r
S
LOQ ¼ 10 r
S
where r is the standard deviation of replicate determination
values under the same conditions as for the sample analysisInter-day (n= 5)
cisionc Accuracyd CBZ foundb Precisionc Accuracyd
7 2.5 2.04 1.62 2.00
8 1.00 4.06 1.17 1.50
1 0.83 6.08 1.53 1.33
6 2.00 0.49 2.38 2.00
5 3.00 1.01 1.92 1.00
5 2.00 1.54 1.27 2.67
6 1.00 2.03 2.01 1.50
1 0.33 3.02 1.87 0.67
1 1.50 4.07 1.50 1.75
trophotometric methods are in lg ml1.
methods and statistical evaluation.
D)a
Spectrophotometric (method A) Spectrophotometric (method B)
100.4 ± 1.81 99.12 ± 1.92
t= 2.09 t= 0.75
F= 2.00 F= 2.25
96.07 ± 2.24 97.23 ± 1.76
t= 0.57 t= 0.52
F= 2.79 F= 1.72
at the 95% conﬁdence level is 6.39.
sample.
lg ml1) Founda ± SD % Recovery ± RSD
0.93 ± 0.02 93.16 ± 2.15
3.61 ± 0.07 90.12 ± 1.94
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304 K. Basavaiah, S.A.M. Abdulrahmanin the absence of the analyte and S is the sensitivity, namely the
slope of the calibration graph. In accordance with the above
equations, the LOD values are 0.05 and 0.14 lg ml1 for meth-
ods A and B, respectively with corresponding LOQ values of
0.15 and 0.42 lg ml1.
3.3.2. Accuracy and precision
To evaluate the accuracy and precision of the methods, pure
drug solution at three different levels (within the working lim-
its) was analyzed, each determination being repeated seven
times. The relative error (%) and relative standard deviation
(%) were less than 3.0 and indicate the high accuracy and pre-
cision for the methods (Table 3). For a better picture of repro-
ducibility on a day-to-day basis, a series of experiments were
performed in which standard drug solution at three different
levels was determined each day for 5 days with all solutions
being prepared afresh each day. The day-to-day relative stan-
dard deviation values were in the range of 1.17–2.38% and
represent the best appraisal of the methods in routine use.
These results are also given in Table 3.
3.3.3. Selectivity
In order to evaluate the selectivity of the proposed methods for
the analysis of pharmaceutical formulations, the effect of the
presence of common excipients, such as talc, starch, lactose,
glucose, sodium alginate, calcium gluconate and magnesium
stearate was tested for possible interference in the assay by pla-
cebo blank. It was conﬁrmed that the change in the titrant va-
lue and the absorbance with respect to the water blank was
caused only by the analyte. A separate test was performed
by applying the proposed methods to the determination of
CBZ in a synthetic mixture and the percent recoveries of
CBZ were 101.3 ± 2.13, 98.65 ± 1.96 and 97.24 ± 2.02
(n= 5) by titrimetric, spectrophotometric method A and
method B, respectively, suggesting that no signiﬁcant interfer-
ence by the excipients in the assay of CBZ under the described
optimum conditions.
3.3.4. Application to assay of pharmaceutical formulations and
spiked urine sample
The proposedmethods were successfully applied to the determi-
nation of CBZ in formulations (tablet and syrup) (Table 4). The
results obtained were statistically compared with those of the
ofﬁcial method (British Pharmacopoeia, 1973) by applying
the Student’s t-test for accuracy and F-test for precision. The
ofﬁcial method consisted of measurement of the absorbance
of the alcoholic extract of the tablets at 285 nm. From Table
4, it is clear that the calculated t-value and F-value at 95% con-
ﬁdence level did not exceed the tabulated values of 2.78 and
6.39, respectively, for four degrees of freedom. The results indi-
cated that there is no difference between the proposed methods
and the ofﬁcial method with respect to accuracy and precision.
The proposed spectrophotometric methods were also applied to
the determination of CBZ in spiked human urine sample and
the results are presented in Table 5. Accuracy and validity of
the proposed methods were further ascertained performing
recovery experiments via the standard addition procedure.
When the tablet powder or syrup (pre-analyzed) spiked with
known amounts of pure CBZ at three different concentration
levels (50%, 100% and 150% of the quantity present in the tab-
let powder or syrup) was analyzed by the proposed methods,
the recoveries of pure drug added were quantitative (Table 6).
Utilization of bromination reactions for the determination of carbamazepine using bromate–bromide mixture 3054. Conclusion
This is the ﬁrst report on the assay of carbamazepine by titrime-
try and the third by visible spectrophotometry. In particular,
the titrimetry is much simpler in technique, more rapid than
all the methods reported so far for carbamazepine and it is
applicable over a micro range (1.00–7.50 mg), yet provides very
accurate and precise results. The proposed spectrophotometric
methods are highly sensitive than many reported methods such
as HPLC (Demirkaya and Kadioglu, 2005, 2008) [0.25–
25 lg ml1], HPLC (Yuan et al., 2003) [5.0–25 lg ml1], LC
(Predrag et al., 2009) [100–500 lg ml1], GC (Kadioglu and
Demirkaya, 2007) [2.0–30 lg ml1], UV-spectrophotometry
(Tatar Ulu, 2006) [4.0–10 lg ml1], UV-spectrophotometry
(Demirkaya and Kadioglu, 2008) [1.25–25.0 lg ml1], visible
spectrophotometry (Rao and Murty, 1982) [10.0–100 lg ml1]
and visible spectrophotometry (Agrawal et al., 1989) [4.0–
80 lg ml1]. Moreover, the proposed methods can be per-
formed at milder experimental conditions without heating or
extraction step. The proposedmethods rely on the use of simple,
cheap and readily available chemicals and techniques but pro-
vide a sensitivity comparable to that achieved by sophisticated
and expensive technique like HPLC. Thus, they can be used
as alternatives for rapid and routine determination of bulk sam-
ple and formulations.
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